GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medesis Pharma SA (XPAR:ALMDP) » Definitions » YoY Rev. per Sh. Growth

Medesis Pharma (XPAR:ALMDP) YoY Rev. per Sh. Growth : -90.16% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Medesis Pharma YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Medesis Pharma's YoY Rev. per Sh. Growth for the quarter that ended in Jun. 2024 was -90.16%.

Medesis Pharma's Revenue per Share for the six months ended in Jun. 2024 was €0.01.

Medesis Pharma YoY Rev. per Sh. Growth Historical Data

The historical data trend for Medesis Pharma's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medesis Pharma YoY Rev. per Sh. Growth Chart

Medesis Pharma Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial 1,733.33 -9.09 -56.00 -50.00 445.45

Medesis Pharma Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -57.89 50.00 662.50 100.00 -90.16

Medesis Pharma YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Medesis Pharma's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2023 )
=(Revenue per Share (A: Dec. 2023 )-Revenue per Share (A: Dec. 2022 ))/ | Revenue per Share (A: Dec. 2022 ) |
=(0.06-0.011)/ | 0.011 |
=445.45 %

Medesis Pharma's YoY Rev. per Sh. Growth for the quarter that ended in Jun. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Jun. 2024 )
=(Revenue per Share (Q: Jun. 2024 )-Revenue per Share (Q: Jun. 2023 )) / | Revenue per Share (Q: Jun. 2023 )) |
=(0.006-0.061)/ | 0.061 |
=-90.16 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medesis Pharma YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Medesis Pharma's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Medesis Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medesis Pharma SA (XPAR:ALMDP) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
XPAR:ALTHX XPAR:ALBPS XPAR:ALNEV XPAR:ALINT XPAR:ALTME XPAR:ALOPM XPAR:ALTAO VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270 SMMT RPRX XKRX:196170
Traded in Other Exchanges
N/A
Address
Loree des Mas, Avenue du golf, Baillargues, Montpellier, FRA, 34670
Website
https://www.medesispharma.com
Medesis Pharma SA is a clinical development stage biopharmaceutical company. It is engaged in the development of orally administered molecule drug candidates to expand therapeutic usefulness to address major unmet medical needs.

Medesis Pharma Headlines

No Headlines